Immuno-Oncology Summit
03-04

October 2018

Austria

Vienna

Hilton Garden Inn Vienna South

Hertha-Firnberg-Straße 5, 1100

About

We are pleased to invite you to the Immuno-Oncology Summit, scheduled for October 3rd -4th, 2018, in Vienna, Austria. This Summit is focused on Immuno-Oncology this rapidly evolving field and the most promising new cancer treatment approach since the development of the first chemotherapies. It will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Immuno-Oncology, and discuss the latest advancements and improvements in research and development, business oppor...

We are pleased to invite you to the Immuno-Oncology Summit, scheduled for October 3rd -4th, 2018, in Vienna, Austria. This Summit is focused on Immuno-Oncology this rapidly evolving field and the most promising new cancer treatment approach since the development of the first chemotherapies. It will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Immuno-Oncology, and discuss the latest advancements and improvements in research and development, business opportunities in partnering and investing. We will discuss key findings, critical insights, as well as recommendations for accelerating development in the field. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna, this coming October!

more info
Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Scientists, Investigators and Managers specialising in:

  • Oncology
  • Drug Discovery
  • Antibody Engineering
  • Cancer Immunotherapy
  • Haematology
  • Genetics and Genomics
  • Bioinformatics
  • Cancer Genomics
  • Cell Therapy Research
  • Preclinical Development
  • Pathology
  • Regulatory Affairs
  • Clinical Diagnostics
  • Drug Delivery
  • Antibody Discovery
  • Immuno-Oncology
  • Translational Medicine
  • Oncology Biomarkers
  • Business Development
  • Infection and Immunity
  • Cell & Gene Therapy
  • Tumour Immunology
  • Vaccines Development
Key Practical Learning Points of the Summit

Advanced methods, developments and strategies in Immuno-Oncology
The success of antibodies in therapeutics and engineering
The true potential of the next generation immune checkpoint pathways
Preclinical Science
Clinical Research and clinical trials in therapeutic areas
Translation of Immuno-Oncology
Revolutionary cancer treatment with personalised cancer vaccines
Managing unique immune-mediated adverse reactions and toxicity effects
Regulatory aspects of the EU and the rest of the world
New industry trends
Speakers
Dr. Kandeepan Ganeshalingam, UK

Executive Director / Therapeutic Area Head Oncology / European Clinical Dev., MRL

Merck Sharp & Dohme Ltd.

Dr. Ivan Diaz-Padilla, CH

Senior Medical Director / Breast Cancer Franchise / Oncology Global Dev.

Novartis Pharma AG

Dr. Riccardo Belli, CH

Medical Director / Global Clinical Dev.

Novartis

Ioannis Karydis, UK

Associate Professor in Oncology Cancer Sciences Unit / Southampton University Hospitals

University of Southampton, UK

Dr. John Maher, UK

Clinical Immunologist & Immunopathologist / “CAR Mechanics” Research Group

King’s College London

Dr. Helen K. Angell, UK

Associate Principal Scientist, Immuno-Oncology / Translational Science | Oncology IMED Biotech Unit

AstraZeneca

Elena Spanjaard, US

Director Regulatory Affairs

Pfizer

Dr. Jun Wang, CH

Senior Medical Director / Cancer Immunotherapy

Genentech/Roche

Dr. Alexander Sternjak, DE

Scientist

AMGEN Research (Munich) GmbH

Dr. Geert С. Mudde, AT

CSO

OncoQR ML GmbH

Sara Colombetti, CH

Head of Oncology Discovery Pharmacology

Roche Innovation Center Zurich

Dr. Agnete Fredriksen, NO

President and Chief Scientific Officer

Vaccibody

Vijay Kasturi, US

Senior Medical Director & Global Medical Affairs Lead - Avelumab & Genitourinary Cancer Portfolio

EMD Serono, Inc.

Annual

Events

Previous Year Attendees
  • National Center for Tumor Diseases (NCT) Heidelberg Germany

  • Hamamatsu Tissue Imaging and Analysis Center, BIOQUANT Germany

    Scientific Director

  • Genentech/Roche Switzerland

    Senior Medical Director, Cancer Immunotherapy

  • QuintilesIMS UK

    Senior Director, Therapeutic Science & Strategy

  • Shire Austria

    Director R&D, Antibody Technology

  • Roche Innovation Center Zurich Switzerland

    Pharmacology Research Area

  • Silenseed LTD Israel

    CEO

  • University of Southampton UK

    Associate Professor in Oncology, Cancer Sciences Unit

  • GlaxoSmithKline UK

    Head of Discovery & New Technologies, Oncology Cell Therapy Unit, Oncology R&D

  • Novartis Pharma AG Switzerland

    Global Clinical Leader, Oncology Clinical Development

  • AstraZeneca UK

    Medical Director IO-Gmed

  • AMGEN GmbH Germany

    Medical Development Director - TA Bone/Inflammation/Neuroscience

  • GE Healthcare UK

    Product Leader, Cell Therapy

  • NanoTemper Technologies GmbH Munich Germany

    Senior Application Scientist & Sales

  • Paul-Ehrlich-Institut Langen Germany

    Head of Tissue Engineering & Somatic Cell Therapeutics

  • Glythera Ltd UK

    Senior Development Scientist

  • Merck Serono S.p.A. Italy

    Biotech Scientific Manager

  • Agensys, an affiliate of Astellas Pharma, Inc. USA

    Senior Director Pharmacology

  • eTheRNA immunotherapies NV Belgium

    Chief Scientific Officer

  • Lonza Cologne GmbH Germany

    Sales Specialist

  • IPSEN Innovation SAS France

    Senior Regulatory Product Manager

  • Novartis Pharma GmbH Germany

    Medical Advisor

  • Ablynx NV Belgium

    Senior Research Fellow

  • Charles River UK

    Senior Director Scientific Alliances

  • Orion Clinical Services Ltd. UK

    Associate Medical Director

  • NeoGenomics Laboratories USA

    Vice President Pharma Services, International Sales & Business Development

  • BioNTech Small Molecules GmbH Germany

    Head of Small Molecules

  • Personalis, Inc. USA

    Executive Account Manager D/A/CH

  • Illumina GmbH Germany

    District Marketing Manager, Central Europe

  • Lonza AG Switzerland

    R&T Pharma & Biotech

  • Advanced Cell Diagnostics SRL Italy

    Senior Director Europe, ACD SRL

  • Symphogen Inc. USA

    V.P of Project Management & Clinical Operation

  • Illumina Cambridge Ltd UK

    Director, Business Development

  • Myriad RBM, Inc. USA

    Director, Business Development

  • HISTALIM, SARL France

    Project Manager

  • Heraeus Deutschland GmbH & Co. KG Germany

    Global Head Projectmanagement Pharmaceutical Ingredients

  • Crown Bioscience Inc. USA

    Director of Business Development

  • Invectys SA France

    CEO

  • Glycotope GmbH Germany

    CMO

  • Bayer Pharma AG Germany

    Head Clinical Pharmacology Oncology

  • Polypure AS Norway

    COO

  • ProteinSimple USA

    Global Pharma and Partners Manager - Simple Plex



more info
Sponsors and Partners

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner